Background {#s1}
==========

The enzyme diacylglycerol acyltransferase (DGAT) \[EC 2.3.1.20\] catalyses the chain terminating step in triacylglycerol (TG) biosynthesis. This utilizes diacylglycerol (DG) as a substrate in competition with phospholipids biosynthesis through the Kennedy pathway. TG and phospholipids thus synthesized have distinct physicochemical characteristics that could have an impact on intracellular membrane biogenesis. The fatty acid profile of these lipids is well maintained due to the substrate specificities of DGAT and DG­utilizing enzymes through deacylation-reacylation of these lipids. TG is potentially synthesized and sequestered in spatial cells such as hepatocytes, adipocytes, plant seeds and oleaginous fungi \[[@R01]--[@R04]\]. DGAT is assumed to be involved in the specific augmentation of TG accumulation in these types of cells. Manipulation of DGAT could regulate the quality and quantity of TG. However, the molecular role of DGAT is still unclear despite its important role in TG associated disorder of mammalian cells. A very few reports describe its purification \[[@R05]--[@R07]\], and the purified fraction contained several peptides, among which the catalytic subunit remains to be identified. *Mortierella ramanniana var. angulispora* is known to accumulate lipids (especially TG). TG contains relatively large amount of γ­linolenic acid. The fungus is known as a potent producer of γ­linolenic acid and essential fatty acids by fermentation \[[@R08]--[@R10]\]. Such oleaginous fungi are expected to exhibit amplified expression of specific mechanisms for TG biosynthesis and TG sequestration in lipid bodies taking advantage of oleaginicity. DGAT has been characterized in this fungus to explain the mechanism of TG biosynthesis and sequestration \[[@R11],[@R12]\]. DGAT activity was higher in the lipid body fraction as compared to that in membrane fraction. It has also been found that DGAT is activated by specific anionic phospholipids \[[@R13]\] providing insights to the regulation. We reported the purification of DGAT from the lipid body fraction of the fungus \[[@R14]\]. This allowed for further studies on TG biosynthesis. Here, we describe the binding of the inhibitors with the protein model of DGAT type 2B.

Methodology {#s2}
===========

DGAT sequence {#s2a}
-------------

The sequence of the diacylglycerol acyltransferse (DGAT) type 2B from *Mortierella ramanniana var. angulispora* (Protein_ID = AAK84180.1) comprising of 355 residues was retrieved from GenBank.

Template structure selection {#s2b}
----------------------------

A suitable template (PDB-ID: 1K30) was selected using PSIBLAST \[[@R15]\] search with PDB. The selected template is DGAT from *Cucurbita moschata* with more than 70% sequence similarity.

Modeling of DGAT type 2B {#s2c}
------------------------

The template (1K30) and target (DGAT Type 2B) sequences were aligned using **mGenThreader Server**. \[[@R16]\] After careful examination for the potential alignment errors, the automated comparative protein modeling program **MODELLER 9v2** \[[@R17]\] was employed to build the model.

Structure submission to Protein Model Database {#s2d}
----------------------------------------------

The molecular configuration of DGAT is investigated using data described elsewhere \[[@R14]\]. The authors thus submitted the two protein models for DGAT as follows: (a) DGAT 2B model submitted to Protein Model Database in France during August 2007 (Protein ID: **PM 0074978**) and (B) DGAT 2A model submitted to Protein Model Database in France during August' 2007 (Protein ID: **PM 0074981**).

Discussion {#s3}
==========

Five theoretical models of DGAT Type 2A and Type 2B were generated by MODELLER. The generated models of DGAT Type 2A and Type 2B are represented in [Figure 1(A) and 1(B)](#F1){ref-type="fig"}, respectively. Among the five DGAT Type 2B models, the lowest energy structure was DGAT2A 1 and DGAT2B as shown in [Figure 1(A) and 1(B)](#F1){ref-type="fig"}, respectively. In order to select the best model, we checked the structural validity of DGAT Type 2B by PROCHECK. The torsion angles φ and ψ of 88.9% of the residues had values within the most favored regions and only 0.3% of the residues had values within disallowed regions. The overall G­factor is a measure of the overall normality of the structure and low G­factors indicate that residues have unlikely conformations. The overall value is obtained from an average of G­factors for all residues in structure. X­ray structure of DGAT Type 2A with resolution of 2.0 Å and a G­factor of 0.26 Å. The stereo­chemical quality of a protein model can be judged by the use of φ and ψ scatter plots. The incorrect structures generally have a larger fraction of residues in the disallowed regions \[[@R18]\]. The model of DGAT Type 2B has only 0.3% of its residues in the disallowed regions. Thus, the model satisfies criteria of a reasonably acceptable model.

The catalytic mechanisms of DGAT in various fungi are similar. However, they show significantly different substrate specificities in various species. The active site of DGAT Type 2B was hypothecated into two regions: (a) catalytic site and (b) primer binding site. The mechanism of action of DGAT involves a catalytic triad composed of an asparagine, a histidine, and the catalytic cysteine residues in the catalytic site. The catalytic triad of DGAT comprises of Cys112, His238, and Asn268. These residues are conserved in DGAT Type 2B (Cys113, His246, and Asn276). The enzyme DGAT Type 2B catalyzes carbon­carbon bond formation by condensing an acyl primer with an elongating carbon source often attached to a holo­ACP \[[@R19]\]. Hence, the primer binding site of DGAT is important to defining of substrate specificities. The isoformic structure was described elsewhere using the purification data reported by Kamisaka et al. \[[@R14]\]. It should be noted that the function of Type 2A is still unclear and inter conversion of inactive to active form of DGAT probably requires certain hormonal and/or biochemical and/or molecular modulator. We docked Sphingosine, Trifluoroperazine, PhosphatidicAcid, Lysophospatidylserine, KCl and 1, 2­diolein to DGAT type 2B. These are lavonoids (a group of polyphenolic compounds) are widely distributed through out the plant kingdom with antibacterial activity. The interactions of these compounds with DGAT type 2B are described.

Ligand docking was carried out for DGAT Type 2B with these inhibitors ([Figure: 2A ‐ 2F](#F2){ref-type="fig"}). Lowest models of DGAT Type 2B in complex with inhibitors are shown in [Figure: 2A ‐ 2F](#F2){ref-type="fig"}. As shown in [figure 2B](#F2){ref-type="fig"}, the side chains of Cys113, Phe308, Ser153 and Asn249 play important roles on hydrogen bonds with 7­, 4­ and 4­hydroxyl groups of naringenin, respectively. However, in the case of phosphatidic acid, only the side chain of Ser153 forms hydrogen bond with 7­hydroxyl group of apigenin. The double bond of C2­C3 position of C ring in phosphatidic acid provides a structural rigidity compared with lysophospatidylserine. This rigidity interrupted an H­bond between DGAT Type 2B and Lysophospatidylserine. The results described here is in close resemblance to the data described elsewhere \[[@R14]\]. It is speculated that the outer membrane of fungus acts as a barrier against lysophospatidylserine. However, it has already been reported that the purified DGAT utilizes a broad range of molecular species of diacyl glycerol and acyl­CoA as substrates \[[@R14]\]. The highest activity of the purified enzyme was observed with *sn*­1, 2­diolein and lauroyl­CoA. Data show that anionic phospholipids such as phosphatidic acid (PA) activated the purified enzyme. Reports also show that sphingosine dose dependently inhibited DGAT activity activated by PA and basal activity without PA. These results explain for the molecular function of DGAT and the mechanism of triacylglycerol biosynthesis.

Conclusion {#s4}
==========

The three­dimensional structure model of DGAT Type 2B was created and described. Ligand docking shows that lysophospatidylserine provides the proper binding model in active site of DGAT Type 2 B with intensive hydrogen bonding network. Nevertheless, the comprehensive studies pertaining to elucidation of structural and functional models of Type 2A of DGAT as well as other TG biosynthesis enzymes may provide new insights into the molecular mechanism of these key players in fungal biotechnology.
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